[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"persian-gulf-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:persian-gulf-syndrome":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100555676","phase-3-coenzyme-q10-for-gulf-war-illness-a-replication-study-100555676",false,"NCT06515184","Coenzyme Q10 for Gulf War Illness: A Replication Study","Inclusion Criteria:\n\n* Meets both CDC and Kansas deployment and symptom inclusion criteria.\n* Does not have a disqualifying condition.\n* Able to travel to a local Quest facility for study blood draws.\n* Adequate internet access to allow ZoomPro visit participation and remote survey completion.\n* Health prior to the Gulf War rated as \"very good\" or \"excellent\" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms).\n* Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation.\n\nExclusion Criteria:\n\n* Participating in another clinical trial.\n* Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.\n* On Coumadin\u002F warfarin.\n* Unable to participate for the required duration of the study.","ALL","50 Years",{"count":18,"type":19},192,"ESTIMATED","INTERVENTIONAL",[22],"PHASE3","The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.",[25,26,27],"Gulf War Syndrome","Persian Gulf Syndrome","Mitochondrial Disorder, Respiratory Chain","RECRUITING","2026-04-27",{"date":31,"type":32},"2026-05-01","ACTUAL",{"date":34,"type":32},"2024-09-13",{"date":36,"type":19},"2027-12",{"name":38,"class":39},"University of California, San Diego","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":15,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":20,"phases":51,"briefSummary":53,"conditions":54,"keywords":59,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100571143","confirming-the-effects-of-acupuncture-treatments-to-relieve-symptoms-of-gulf-war-illness-100571143","NCT06716411","Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness","CARE","Inclusion Criteria:\n\n* Deployed to the Gulf Theater of operations (as defined by 38 CFR 3.317, includes Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, the United Arab Emirates, Oman, the Gulf of Aden, the Gulf of Oman, the Persian Gulf, the Arabian Sea, the Red Sea, and the airspace above all of these locations) between August 1990 and the present date\n* Have at least 2 of the following symptoms from the 3 CDC clusters of symptom that have lasted for more than 6 months. Each symptom cluster must be characterized as mild-moderate or severe, with at least one symptom in each cluster required to be severe. The clusters are:\n\nA. Fatigability: fatigue 24 hours or more after exertion B. Mood and Cognition: feeling depressed; feeling irritable; difficulty thinking or concentrating; feeling worried, tense, anxious; problems finding words; or problems getting to sleep C. Musculoskeletal: joint pain or muscle pain\n\nExclusion Criteria:\n\n* Currently enrolled in another clinical trial\n* Have another disease that likely could account for the symptoms, as determined by our Medical Monitor\n* Severe psychiatric illness (in the last 2 years psychiatric hospitalization, suicidal attempt, alcohol or substance abuse, use of antipsychotic medication) as measured by the Primary Care Evaluation of Mental Disorder (Prime MD).\n* Unable to complete the protocol on based on the evaluation of the Medical Monitor.","18 Years",{"count":50,"type":19},200,[52],"NA","This unblinded Phase II clinical trial will test the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners will have had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness will be randomized to either six months of biweekly acupuncture treatments (group 1, n=100) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=100). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).",[26,25,55,56,57,58],"Multiple Chronic Illnesses","Occupational Diseases","War-Related Injuries","Wounds and Injuries",[60,61,62,63,64],"Acupuncture","Gulf War Illness","Complex Medical Illness","Chronic Multisymptom Illness","Veteran","2026-04-02",{"date":67,"type":32},"2026-04-03",{"date":69,"type":32},"2026-02-03",{"date":71,"type":19},"2028-09-30",{"name":73,"class":39},"University of Utah",10]